The human immunodeficiency virus type 1 (HIV-1) trimeric envelope glycoprotein (Env) is located on the surface of virus particles and is the target of neutralizing antibodies (NAbs), which are produced during infection. This evidence concerns the gene ERVW-1 and infection.